Ovarian Cancer Research Alliance

According to the Ovarian Cancer Research Alliance consolidated audit of December 31, 2020 (Note 1, Nature of Operations):

"The Ovarian Cancer Research Fund, Inc. ('OCRF') D/B/A Ovarian Cancer Research Alliance ('OCRA') is a corporation which was organized in the State of New York as a not-for-profit entity on December 8, 1994. OCRA executed a D/B/A on October 3, 2018 to assume the name Ovarian Cancer Research Alliance. OCRA previously operated as the Ovarian Cancer Research Fund Alliance ('OCRFA'), which name was adopted on January 1, 2016, the date on which the operations of the Ovarian Cancer National Alliance ('OCNA') were consolidated with OCRF."

According to the Ovarian Cancer Research Alliance (OCRA) consolidated audit of December 31, 2020 (Note 2 re: Contributed Services), OCRA received in-kind "contributed services for advertising services and professional fees that were utilized principally in OCRA's program operations" during 2020 on which it placed a total value of $599,310.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

According to the Ovarian Cancer Research Alliance consolidated audit of December 31, 2020 (Note 3, Concentrations of Credit Risk):

"One donor represents approximately 12% of contribution revenue for each of the years ended December 31, 2020 and 2019."

According to the Ovarian Cancer Research Alliance (OCRA) consolidated audit of December 31, 2020 (Note 6, Note Payable – Paycheck Protection Program):

"In April 2020, OCRA entered into a Paycheck Protection Program Term Note (the 'PPP Note') with Chase Bank in the amount of $402,581. The PPP Note was issued to OCRA pursuant to the Coronavirus, Aid, Relief, and Economic Security Act's (the 'CARES Act')...Paycheck Protection Program (the 'Program'). Under the Program, all or a portion of the PPP Note may be forgiven in accordance with the Program requirements. OCRA has used all of the proceeds of the PPP Note to pay its qualified expenses...and substantially met all conditions. Therefore, in June 2021, OCRA submitted its application for loan forgiveness.

"On July 6, 2021, the forgiveness of the $402,581 loan under the Program was approved and is shown in the [audited] consolidated statements of activities as 'Grants – government'.

"Consequently, OCRA has elected to recognize the entire loan balance as income... Under this [accounting standards guidance], the PPP Note forgiveness is dependent on meeting certain conditions and would be considered a conditional contribution. Conditional contributions are recognized as income when the conditions on which they depend are met."

According to the Ovarian Cancer Research Alliance (OCRA) consolidated audit of December 31, 2020 (Note 12, Subsequent Events):

"Subsequent to year end, in March 2021, OCRA was eligible and entered into an additional PPP [Paycheck Protection Program] Note with Chase Bank in the amount of $403,500. This note has the same terms as described in Note 6 [cited separately, above].

"OCRA believes that it is in compliance with the Program requirements, and it expects to receive full forgiveness of the additional PPP Note."